Doctors blast Biogen Alzheimer approval as ‘regulatory failure’
The New England Journal of Medicine opinion piece is another sign of persistent furor over the agency’s decision.
The Japan Times
Surprising stocks see windfall as Japan tops Olympic medal table
The nation’s haul of 11 gold medals is lifting everything from real estate stocks to the shares of seafood vendors with the most…
Billionaire who missed out on TikTok is now trying to beat it
Flush with cash from an IPO, Kuaishou is cranking up spending to close the gap with ByteDance, more than four times its size.
Netflix promises growth ahead after languid start to year
The company added 1.54 million customers in the second quarter, above the 1.12 million forecast by analysts, but it’s a far cry…
Flush with unicorns, India’s tech moment arrives
Last week marked a watershed for technology startups in India, as a record bout of fundraising shifted attention to the world’s…
Kioxia eyes listing on Tokyo bourse in September after postponement
The envisaged listing of Kioxia, formerly known as Toshiba Memory Holdings Corp., comes as robust demand for semiconductors is…
Toshiba management woes seen deepening after strong shareholder rebuke
The shareholder revolt, led by foreign activist investors, against the approval of Nagayama as chairman has added to the tumult…
Fastly failure: Why a slew of major websites went offline
The cascade of failures across the web turned a mere “service configuration” into a global outage that hit large companies and…
All Blacks players fret over team’s fate if Silver Lake buys in
A move by the U.S. private equity firm to purchase a stake of New Zealand Rugby’s commercial operations has drawn criticism.
In first since 2012, Bank of Japan went a month without buying ETFs
The last time that the BOJ did not make any ETF purchases for a whole month was in December 2012.